Psychotropic Medication Patterns for American Indian Children in Foster Care

2018 ◽  
Vol 28 (3) ◽  
pp. 225-231 ◽  
Author(s):  
David Glesener ◽  
Gwendolyn Anderson ◽  
Xuan Li ◽  
Jacob Brown ◽  
James Amell ◽  
...  
2021 ◽  
Vol 111 ◽  
pp. 104805
Author(s):  
Ashley L. Landers ◽  
Sharon M. Danes ◽  
Avery R. Campbell ◽  
Sandy White Hawk

2020 ◽  
Vol 2 (1) ◽  
pp. 3-20 ◽  
Author(s):  
Conor O’Brien ◽  
John T. Rapp ◽  
Erica D. Kierce

Approximately one third of children in foster care in the U.S. receive psychotropic medication; however, few studies have evaluated the extent to which either the number or dosage of drugs changes across time. We conducted a retrospective descriptive study of Medicaid files for 30 individuals placed in a foster care system that included an analysis of 10 consecutive visits with a prescribing practitioner spanning 8–14 months. Specifically, we evaluated the data for evidence of deprescribing. Results indicate practitioners changed psychotropic medication during 70% of visits and most changes involved removing and adding psychotropic medication within the same class. Results also show 60% of visits across participants involved prescriptions for four or more psychotropic medications, whereas only 0.33% of trials involved no psychotropic medication. Furthermore, results show the mean number of psychotropic medications per foster child at the end of the study ( M = 3.97) did not decrease in comparison to the start of the study ( M = 3.53). Taken together, these results indicate that prescribers do not regularly engage in a clear deprescribing process for psychotropic medication when serving foster youth. We discuss some limitations to the current study and directions for future research on prescribing patterns with foster children.


2014 ◽  
Vol 65 (12) ◽  
pp. 1452-1457 ◽  
Author(s):  
Susan dosReis ◽  
Ming-Hui Tai ◽  
David Goffman ◽  
Sean E. Lynch ◽  
Gloria Reeves ◽  
...  

2012 ◽  
Vol 34 (8) ◽  
pp. 1492-1499 ◽  
Author(s):  
David Rubin ◽  
Meredith Matone ◽  
Yuan-Shung Huang ◽  
Susan dosReis ◽  
Chris Feudtner ◽  
...  

1999 ◽  
Vol 9 (3) ◽  
pp. 135-147 ◽  
Author(s):  
BONNIE T. ZIMA ◽  
REGINA BUSSING ◽  
GIA M. CRECELIUS ◽  
AARON KAUFMAN ◽  
THOMAS R. BELIN

Author(s):  
Angela You Gwaltney

Children in foster care experienced abuse, neglect, or dependency, and for the safety and well-being of the child, must be taken out of their biological home. Not surprisingly, children in foster care have higher rates of serious emotional and behavioral problems. Although pharmacological treatments can be an important component of the treatment plan, there seems to be a higher rate of use than would be expected. An estimated 13-25% of foster children are prescribed mind- and mood-altering medication vs. 4% in the general population. Children in foster care are considered a vulnerable population and research involving these children justifiably requires additional measures to ensure their protection. As a result, studies on the use of psychotropic medication among youth in foster care have relied primarily on secondary data‚ typically administrative data. This study used linked administrative datasets to rigorously examine the effect of psychotropic medication on foster care experiences and outcomes among children who entered foster care in North Carolina between March 2006 and June 2012. The dataset was constructed by linking the North Carolina’s child welfare administrative records (also known as the Services Information System [SIS]) with the Medicaid claims database (also known as the Eligibility Information System [EIS]) for medical and mental health services received by the foster youth. Inverse probability of treatment weighting was calculated and applied to mimic a randomized study. Results revealed that children on medication stayed in care longer, less likely to experience placement disruption, and more likely to exit to adoption.


Sign in / Sign up

Export Citation Format

Share Document